From: Promoting population health with public-private partnerships: Where’s the evidence?
Characteristics of the PPP or the evaluation | N totala | Conclusions regarding PPP in health promotion | P Value | |
---|---|---|---|---|
Critical/Semi-critical N (%) | Supportive/Tentatively supportive N (%) | |||
Health problem targeted | 0.040 | |||
Non-communicable Disease | 15 | 8 (53.3) | 7 (46.7) | |
Infectious disease (TB, Malaria, HIV) | 7 | 0 (0.0) | 7 (100.0) | |
Other b | 3 | 1 (33.3) | 2 (66.7) | |
Potential for conflict between business interests of private partner and the health promotion activity | 0.010 | |||
High potential | 10 | 7 (70.0) | 3 (30.0) | |
Moderate potential | 4 | 1 (25.0) | 3 (75.0) | |
Low potential | 11 | 1 (9.1) | 10 (90.9) | |
Independence of evaluation | 0.000 | |||
Yes | 10 | 8 (80.0) | 2 (20.0) | |
No | 14 | 0 (0.0) | 14 (100.0) | |
Unclear | 1 | 1 (100.0) | 0 (0.0) | |
Quality of evaluation | 0.003 | |||
Strong | 9 | 7 (77.8) | 2 (22.2) | |
Moderate | 9 | 2 (22.2) | 7 (77.8) | |
Weak | 7 | 0 (0.0) | 7 (100.0) | |
Research Type | 0.412 | |||
Quantitative | 7 | 6 (85.7) | 1 (14.3) | |
Qualitative | 13 | 7 (53.8) | 6 (46.1) | |
Mixed-methods | 5 | 3 (60.0) | 2 (40.0) | |
Evaluation Type | 0.373 | |||
Impact with quantifiable health-related outcomes | 2 | 0 (0.0) | 2 (100.0) | |
Process with quantifiable intermediate outcomes | 11 | 3 (27.3) | 8 (72.7) | |
Process without quantifiable intermediate outcomes | 12 | 6 (50.0) | 6 (50.0) | |
Total | 25 | 9 (36.0) | 16 (64.0) |